Scientific facilitation groups

Our agency brings people together within a variety of groups, such as Coordinated Actions (CAs), workgroups and sub-groups, networks, and task forces.

Last updated on 22 May 2024


The objective is to promote interactions between researchers from different institutions or disciplines, and representatives of patient organisations. These facilitation meetings help to stimulate reflection on specific topics, encourage research collaboration and the design of innovative projects, highlight priority areas for research or, on the contrary, areas that receive less attention and yet are necessary.

Thematic networks


Arbo-France is a multi-disciplinary, multi-institutional French network for scientific watch, surveillance and research in the field of human and animal arboviruses.

ANRS Task Force HBV Cure

The HBV Cure working group aims to contribute actively to the identification of new therapeutic targets and antiviral molecules for a functional cure of the HBV virus.

Coordinated actions

Coordinated Action Tuberculosis

The Coordinated Action aims to facilitate the establishment of collaborative projects, strengthen R&D and propose new diagnostic, therapeutic and vaccine approaches in response to major issues related to tuberculosis.

Coordinated Action on Viral Haemorrhagic Fevers

Viral haemorrhagic fevers (VHFs) encompass a certain number of serious systemic viral infections that can lead to haemorrhagic syndromes. These diseases are highly contagious, highly fatal and difficult to treat with current medical resources. They constitute a global public health concern owing to their potential to emerge and re-emerge and their severity.

Coordinated Action on Respiratory Virus Vaccines

This Coordinated Action is tasked with structuring research on questions related to vaccination, both in the context of clinical studies and ‘real-world’ studies. It will focus on respiratory viruses such as influenza, coronavirus and respiratory syncytial virus.

Coordinated Action on Viral Hepatitis Basic and Translational Research (CA42)

This Coordinated Action drives basic and translational research in the field of viral hepatitis. It explores new areas of interest, establishes future directions and supports researchers in the maturation of their projects.

Coordinated Action on Host-Virus Interactions: Basic and Translational HIV Research (CA41)

This Coordinated Action drives research into the mechanisms regulating HIV replication and persistence, the induction of effective immune responses and remission of infection through patient cohorts and animal models, with the aim of developing curative therapies.

Coordinated Action on Public Health, HIV, Sexual Health and Hepatitis (CA46)

This Coordinated Action takes a multidisciplinary approach to a wide range of research topics in public health, HIV, sexual health and hepatitis, in France and internationally.

Coordinated Action on Infectious Disease Modelling (CA49)

Modelling has become an essential tool for understanding infectious dynamics, at both individual and population levels.

Coordinated Action on Human-to-Human Transmission of Respiratory Viruses (CA51)

This Coordinated Action focuses on the transmission of respiratory viruses. Its objective is to study the formation and emission of infectious respiratory particles by expulsion or exhalation, their transport, inhalation, modes of respiratory system infection, human-to-human transmission in populations, and the associated preventive methods.

Coordinated Action on Respiratory Viruses (CA52)

The Respiratory Virus Coordinated action was created following the REACTing and ANRS MIE workgroups on COVID-19.

Coordinated Action on Sexually Transmitted Infections (CA53)

This Coordinated Action was created in 2022, amid the update of French recommendations made by the CNS and ANRS MIE for the management of HIV infection, viral hepatitis and sexually transmitted infections (STIs).